Alan Bonder, MD: Phase 2 Data for Combination Obeticholic Acid, Bezafibrate in PBC
Bonder explains key therapeutic targets in primary biliary cholangitis and why combination obeticholic acid and bezafibrate may be a promising option.
Beth Israel Deaconess Medical Center Alan Bonder Beth Israel Deaconess Medical Center Alan Bonder Digestive Disease Week
Source: hcplive.com